Both in Pharmaceuticals
Indaptus Therapeutics vs Phathom Pharmaceuticals
Over the past year INDP returned +3.8% and PHAT returned −58.2%; their daily moves had a correlation of 0.05.
INDP +3.8% PHAT −58.2%Growth of $1, one year, split-adjusted
| Metric | INDP | PHAT |
|---|---|---|
| Price | $3.24 | $5.74 |
| Market cap | $431.7M | $466.6M |
| Today | −7.43% | −2.96% |
| 1 month | +29.1% | −14.3% |
| 6 months | +55.0% | −54.4% |
| Year to date | +11.3% | −65.4% |
| 1 year | +0.6% | −57.6% |
| Revenue growth (YoY) | — | +71.1% |
| Gross margin | — | 78.3% |
| Net margin | — | −16.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.7× |
| Net cash | $11.6M | $17.6M |
| Dividend yield | — | — |
| Volatility (60d) | 193.5% | 72.0% |
| Short % of float | 7.4% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).